Examinando por Autor "Moreno Peral, Patricia"

Mostrando 1 - 3 de 3
  • Miniatura
    Publicación
    Clinical practice guidelines with recommendations for peripartum depression: A European systematic review
    (Wiley, 2022-07-15) Motrico, Emma; Moreno Peral, Patricia; Uriko, Kristiina; Hancheva, Camellia; Brekalo, Maja; Ajaz, Erilda; Apter, Gisèle ; Bramante, Alessandra; Conejo Cerón, Sonia; Christoforou, Andri; Dikmen Yildiz, Pelin; Evagorou, Olympia; Fonseca, Ana; Lupattelli, Angela; Nakić Radoš, Sandra; Maach, Nadia al; Rodríguez Muñoz, María de la Fe; Maja Žutić, Mijke P.; Lambregtse van den Berg, Mijke P.; https://orcid.org/0000-0001-5185-1479; https://orcid.org/0000-0002-0720-567X
    Objective This study aims to systematically review all Clinical Practice Guidelines (CPGs) with recommendations for peripartum depression in European countries. Methods A systematic review according to the PRISMA statement was conducted. CPGs focussing on peripartum depression or with at least one specific recommendation for peripartum depression from European countries were selected. Searching was conducted in electronic databases (MEDLINE and PsycINFO), and by contacting professional societies and international experts until November 24th, 2021. Characteristics of the included CPGs and their recommendations were extracted. A methodological quality assessment was conducted using the AGREE-II tool. Results A total of 239 records were identified after duplicate removal. Of these, 54 were examined for full-text inspection. The final selection yielded 14 CPGs from 11 European countries in 10 languages. Of them, 11 provided recommendations on pharmacological treatments, 10 on psychological treatment (e.g., cognitive-behavioural therapy), 10 on screening, 8 on diagnosis, 6 on other treatments (e.g., physical exercise), 5 on prevention, and 5 other recommendations (e.g., provide information). Regarding the overall methodological quality, only five (35.7%) guidelines were rated as of adequate quality, reaching a score ≥ 70% in the overall assessment of the AGREE-II instrument. Of the six AGREE-II domains, applicability scored the lowest and clarity of presentation scored the highest. Conclusion The absence of CPGs in most European countries, the discrepancy in recommendations and the low methodological quality of the guidelines may lead to disparities and inequalities in peripartum depression management in Europe. The COST Action Riseup-PPD highlights key considerations for future guideline developers.
  • Miniatura
    Publicación
    Diagnosis of peripartum depression disorder: A state-of-the-art approach from the COST Action Riseup-PPD
    (Elsevier, 2024-02-01) Nakić Radoš, Sandra; Kömürcü Akik, Burcu; Žutić, Maja; Rodríguez Muñoz, María de la Fe; Uriko, Kristiina; Motrico, Emma; Moreno Peral, Patricia; Apter, Gisèle; Lambregtse van den Berg, Mijke; https://orcid.org/0000-0002-8330-8427; https://orcid.org/0000-0001-6051-4941; https://orcid.org/0000-0001-9197-1096; https://orcid.org/0000-0003-0644-4473; https://orcid.org/0000-0002-0720-567X; https://orcid.org/0000-0003-4130-9090; https://orcid.org/0000-0001-5185-1479; https://orcid.org/0000-0003-1764-5940
    Background Peripartum depression (PPD) is a major depression disorder (MDD) episode with onset during pregnancy or within four weeks after childbirth, as defined in DSM-5. However, research suggests that PPD may be a distinct diagnosis. The goal of this study was to summarize the similarities and differences between PPD and MDD by synthesizing the current research on PPD diagnosis concerning different clinical features and give directions for improving diagnosis of PPD in clinical practice. Methods To lay the groundwork for this narrative review, several databases were searched using general search phrases on PPD and its components of clinical diagnosis. Results When compared to MDD, peripartum depression exhibits several distinct characteristics. PPD manifests with a variety of symptoms, i.e., more anxiety, psychomotor symptoms, obsessive thoughts, impaired concentration, fatigue and loss of energy, but less sad mood and suicidal ideation, compared to MDD. Although PPD and MDD prevalence rates are comparable, there are greater cross-cultural variances for PPD. Additionally, PPD has some distinct risk factors and mechanisms such as distinct ovarian tissue expression, premenstrual syndrome, unintended pregnancy, and obstetric complications. Conclusion There is a need for more in-depth research comparing MDD with depression during pregnancy and the entire postpartum year. The diagnostic criteria should be modified, particularly with (i) addition of specific symptoms (i.e., anxiety), (ii) onset specifier extending to the first year following childbirth, (iii) and change the peripartum onset specifier to either “pregnancy onset” or “postpartum onset”. Diagnostic criteria for PPD are further discussed.
  • Miniatura
    Publicación
    Effectiveness of interventions to prevent perinatal depression: An umbrella review of systematic reviews and meta-analysis.
    (Elsevier, 2023-03-15) Motrico, Emma; Bina, Rena; Kassianos, Angelos P.; Mateus, Vera; Ozteki, Deniz; Rodríguez Muñoz, María de la Fe; Moreno Peral, Patricia; Conejo Cerón, Sonia; Le, Huynh-Nhu
    Background: To date, dozens of systematic reviews (SRs) and meta-analyses (MAs) summarize the effectiveness of preventive interventions for perinatal depression. However, the results are inconclusive, making an urgent need to step up to higher levels of evidence synthesis. Aims: To summarize and compare the evidence from the SR&MA examining the effectiveness of all types of interventions for preventing perinatal depression. Method: PubMed, PsycINFO, Cochrane Database of Systematic Reviews and OpenGrey were searched from inception to December 2022. We selected SR&MA of randomized controlled trials (RCTs) that compared all types of preventive interventions for perinatal depression with control groups whose outcome was the reduction of depressive symptoms and/or incidence of new cases of perinatal depression (PROSPERO: CRD42020173125). Results: A total of 19 SRs and MAs evaluated 152 unique RCTs that included 83,408 women from 26 countries and five continents. The median effect size for any intervention was SMD = 0.29 (95% CI: 0.20 to 0.38). Exercise/physical activity-based, psychological, and any type of intervention showed median effect sizes of 0.43, 0.28 and 0.36, respectively. The degree of overlap among RCTs was slight. According to AMSTAR-2, 79% of them were rated as low or critically low-quality. The strength of evidence, according to GRADE, was poorly reported and, in most cases, was low. Conclusions: Exercise/physical activity-based and psychological interventions have a small-to-medium effect on reducing perinatal depressive symptoms. There is insufficient evidence to conclude that dietary supplements and pharmacological interventions are effective in preventing perinatal depression. There is a need for high-quality SR&MA of RCTs, mainly focusing on universal preventive interventions